Deescalated 225Ac-PSMA-617 versus 177Lu/225Ac-PSMA-617 cocktail therapy: a single-center retrospective analysis of 233 patients

The aim of this work is to evaluate our clinical real-world data obtained with 225Ac-PSMA-617 (AcPSMA), which were acquired under compassionate care regulations in patients with advanced-stage prostate cancer. The objective parameters that could be derived from this evaluation are compared with prev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Rathke, Hendrik (VerfasserIn) , Winter, Erik (VerfasserIn) , Bruchertseifer, Frank (VerfasserIn) , Röhrich, Manuel (VerfasserIn) , Giesel, Frederik Lars (VerfasserIn) , Haberkorn, Uwe (VerfasserIn) , Morgenstern, Alfred (VerfasserIn) , Kratochwil, Clemens (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: Jun. 6, 2024
In: Journal of nuclear medicine
Year: 2024, Jahrgang: 65, Heft: 7, Pages: 1057-1063
ISSN:2159-662X
DOI:10.2967/jnumed.123.267206
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.2967/jnumed.123.267206
Verlag, lizenzpflichtig, Volltext: https://jnm.snmjournals.org/content/65/7/1057
Volltext
Verfasserangaben:Hendrik Rathke, Erik Winter, Frank Bruchertseifer, Manuel Röhrich, Frederik Lars Giesel, Uwe Haberkorn, Alfred Morgenstern, and Clemens Kratochwil

MARC

LEADER 00000caa a2200000 c 4500
001 1915628695
003 DE-627
005 20250716224256.0
007 cr uuu---uuuuu
008 250127s2024 xx |||||o 00| ||eng c
024 7 |a 10.2967/jnumed.123.267206  |2 doi 
035 |a (DE-627)1915628695 
035 |a (DE-599)KXP1915628695 
035 |a (OCoLC)1528017487 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Rathke, Hendrik  |d 1986-  |e VerfasserIn  |0 (DE-588)1151445495  |0 (DE-627)1011715392  |0 (DE-576)497748223  |4 aut 
245 1 0 |a Deescalated 225Ac-PSMA-617 versus 177Lu/225Ac-PSMA-617 cocktail therapy  |b a single-center retrospective analysis of 233 patients  |c Hendrik Rathke, Erik Winter, Frank Bruchertseifer, Manuel Röhrich, Frederik Lars Giesel, Uwe Haberkorn, Alfred Morgenstern, and Clemens Kratochwil 
246 3 3 |a Deescalated 225 Ac-PSMA-617 versus 177 Lu/ 225 Ac-PSMA-617 cocktail therapy 
264 1 |c Jun. 6, 2024 
300 |b Illustrationen 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Im Titel sind die Zahlen 225 und 177 jeweils hochgestellt 
500 |a Gesehen am 27.01.2025 
520 |a The aim of this work is to evaluate our clinical real-world data obtained with 225Ac-PSMA-617 (AcPSMA), which were acquired under compassionate care regulations in patients with advanced-stage prostate cancer. The objective parameters that could be derived from this evaluation are compared with previous literature about AcPSMA and 177Lu-PSMA-617 (LuPSMA). Methods: The medical files of all patients who had received AcPSMA on an individual patient basis at the Heidelberg University Hospital since January 2014 were analyzed retrospectively. Previously published patients were excluded. The remaining patients were tailored into 2 subgroups with different treatment strategies: group 1 received AcPSMA as a deescalated monotherapy, and group 2 received LuPSMA plus AcPSMA as a cocktail regimen. Baseline characteristics, serum prostate-specific antigen (PSA) response, and overall survival were compared with the most appropriate historical controls. Results: Of 287 patients treated, 54 were excluded because of previous publication and 233 were evaluated, 104 of whom received AcPSMA monotherapy (median, 6 MBq). In this group, 55 patients (53%) presented with a best PSA response of at least 50%. The other 129 patients received a cocktail therapy of AcPSMA (median, 4 MBq) plus LuPSMA (4 GBq). In this group, a best PSA response of at least 50% was observed in 74 patients (57%). The median overall survival in the monogroup was 9 mo and in the cocktail group was 15 mo. If adjusted for prognostic baseline characteristics, the efficacy of both regimens was not significantly different. Conclusion: Deescalated treatment activities of AcPSMA or AcPSMA and LuPSMA cocktail regimens present better tolerability with regard to xerostomia than previous regimens of at least 100 kBq/kg while retaining high antitumor activity in poor-prognosis prostate cancer patients. 
650 4 |a 177Lu 
650 4 |a 225Ac 
650 4 |a cocktail 
650 4 |a mCRPC 
650 4 |a PSMA 
650 4 |a TAT 
700 1 |a Winter, Erik  |d 1991-  |e VerfasserIn  |0 (DE-588)1196751358  |0 (DE-627)167862246X  |4 aut 
700 1 |a Bruchertseifer, Frank  |e VerfasserIn  |0 (DE-588)1245175106  |0 (DE-627)1776282523  |4 aut 
700 1 |a Röhrich, Manuel  |d 1983-  |e VerfasserIn  |0 (DE-588)1137027177  |0 (DE-627)893969826  |0 (DE-576)491054769  |4 aut 
700 1 |a Giesel, Frederik Lars  |e VerfasserIn  |4 aut 
700 1 |a Haberkorn, Uwe  |d 1959-  |e VerfasserIn  |0 (DE-588)1022913905  |0 (DE-627)717331245  |0 (DE-576)366166352  |4 aut 
700 1 |a Morgenstern, Alfred  |e VerfasserIn  |4 aut 
700 1 |a Kratochwil, Clemens  |d 1978-  |e VerfasserIn  |0 (DE-588)134026276  |0 (DE-627)559871686  |0 (DE-576)300262787  |4 aut 
773 0 8 |i Enthalten in  |t Journal of nuclear medicine  |d New York, NY : Soc., 1964  |g 65(2024), 7 vom: Juli, Seite 1057-1063  |h Online-Ressource  |w (DE-627)325793603  |w (DE-600)2040222-3  |w (DE-576)09475277X  |x 2159-662X  |7 nnas  |a Deescalated 225Ac-PSMA-617 versus 177Lu/225Ac-PSMA-617 cocktail therapy a single-center retrospective analysis of 233 patients 
773 1 8 |g volume:65  |g year:2024  |g number:7  |g month:07  |g pages:1057-1063  |g extent:7  |a Deescalated 225Ac-PSMA-617 versus 177Lu/225Ac-PSMA-617 cocktail therapy a single-center retrospective analysis of 233 patients 
856 4 0 |u https://doi.org/10.2967/jnumed.123.267206  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://jnm.snmjournals.org/content/65/7/1057  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20250127 
993 |a Article 
994 |a 2024 
998 |g 134026276  |a Kratochwil, Clemens  |m 134026276:Kratochwil, Clemens  |d 910000  |d 911400  |e 910000PK134026276  |e 911400PK134026276  |k 0/910000/  |k 1/910000/911400/  |p 8  |y j 
998 |g 1022913905  |a Haberkorn, Uwe  |m 1022913905:Haberkorn, Uwe  |d 910000  |d 911400  |e 910000PH1022913905  |e 911400PH1022913905  |k 0/910000/  |k 1/910000/911400/  |p 6 
998 |g 1137027177  |a Röhrich, Manuel  |m 1137027177:Röhrich, Manuel  |d 910000  |d 911400  |d 50000  |e 910000PR1137027177  |e 911400PR1137027177  |e 50000PR1137027177  |k 0/910000/  |k 1/910000/911400/  |k 0/50000/  |p 4 
998 |g 1196751358  |a Winter, Erik  |m 1196751358:Winter, Erik  |d 910000  |d 911400  |e 910000PW1196751358  |e 911400PW1196751358  |k 0/910000/  |k 1/910000/911400/  |p 2 
998 |g 1151445495  |a Rathke, Hendrik  |m 1151445495:Rathke, Hendrik  |d 50000  |e 50000PR1151445495  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1915628695  |e 4656530840 
BIB |a Y 
SER |a journal 
JSO |a {"titleAlt":[{"title":"Deescalated 225 Ac-PSMA-617 versus 177 Lu/ 225 Ac-PSMA-617 cocktail therapy"}],"title":[{"subtitle":"a single-center retrospective analysis of 233 patients","title_sort":"Deescalated 225Ac-PSMA-617 versus 177Lu/225Ac-PSMA-617 cocktail therapy","title":"Deescalated 225Ac-PSMA-617 versus 177Lu/225Ac-PSMA-617 cocktail therapy"}],"language":["eng"],"name":{"displayForm":["Hendrik Rathke, Erik Winter, Frank Bruchertseifer, Manuel Röhrich, Frederik Lars Giesel, Uwe Haberkorn, Alfred Morgenstern, and Clemens Kratochwil"]},"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"Jun. 6, 2024"}],"recId":"1915628695","person":[{"role":"aut","given":"Hendrik","display":"Rathke, Hendrik","family":"Rathke"},{"given":"Erik","display":"Winter, Erik","family":"Winter","role":"aut"},{"role":"aut","family":"Bruchertseifer","given":"Frank","display":"Bruchertseifer, Frank"},{"role":"aut","given":"Manuel","display":"Röhrich, Manuel","family":"Röhrich"},{"display":"Giesel, Frederik Lars","given":"Frederik Lars","family":"Giesel","role":"aut"},{"display":"Haberkorn, Uwe","given":"Uwe","family":"Haberkorn","role":"aut"},{"family":"Morgenstern","given":"Alfred","display":"Morgenstern, Alfred","role":"aut"},{"given":"Clemens","display":"Kratochwil, Clemens","family":"Kratochwil","role":"aut"}],"note":["Im Titel sind die Zahlen 225 und 177 jeweils hochgestellt","Gesehen am 27.01.2025"],"relHost":[{"disp":"Deescalated 225Ac-PSMA-617 versus 177Lu/225Ac-PSMA-617 cocktail therapy a single-center retrospective analysis of 233 patientsJournal of nuclear medicine","recId":"325793603","language":["eng"],"titleAlt":[{"title":"JNM"}],"pubHistory":["Nachgewiesen 5.1964 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"name":{"displayForm":["Society of Nuclear Medicine"]},"origin":[{"dateIssuedDisp":"1964-","publisher":"Soc.","publisherPlace":"New York, NY","dateIssuedKey":"1964"}],"corporate":[{"display":"Society of Nuclear Medicine","role":"isb"}],"title":[{"title":"Journal of nuclear medicine","title_sort":"Journal of nuclear medicine","subtitle":"JNM"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["2159-662X","1535-5667"],"zdb":["2040222-3"],"eki":["325793603"]},"part":{"issue":"7","extent":"7","pages":"1057-1063","year":"2024","volume":"65","text":"65(2024), 7 vom: Juli, Seite 1057-1063"},"note":["Gesehen am 13.12.2021"]}],"id":{"doi":["10.2967/jnumed.123.267206"],"eki":["1915628695"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"noteIll":"Illustrationen","extent":"7 S."}]} 
SRT |a RATHKEHENDDEESCALATE6202